Home » Newsletters » BioWorld Science

BioWorld Science

April 1, 1999

View Archived Issues

Aurora and Becton Dickinson announce drug development agreement

Procept receives additional patent allowances for PRO-2000

MGI Pharma to promote Ridaura and Luxiq for Connetics

DSMB completes interim evaluation of Maxamine phase III clinical trials

SciClone receives another approval for Zadaxin

Inflazyme lays plans for phase I testing of IPL-576092

Aquila initiates phase IIb testing of Quilimmune-P

New microbially produced inhibitor of HSP expression in development at Mercian

Temporary platelet inhibition by SM-20302 results in sustained antithrombotic efficacy in dog model

Xenova: year-end 1998 highlights

New microtubule-stabilizing agents developed at Schering

Dopaminergic agents for anxiety, depression and Parkinson's disease disclosed by ADIR

Merck & Co. presents new macrolide immunosuppressants

Protein farnesyltransferase inhibitors emerge from Schering-Plough/Pharmacopeia collaboration

More from ACS meeting: Pfizer presents potent new leukotriene antagonists with oral activity

New antimuscarinic piperidine derivative from Taisho inhibits bladder contractions

Dihydropyridines for reversing MDR presented at Japanese scientific meeting this week

Selective N-type VACC blockers under investigation at Warner-Lambert and Elan

First regulatory approval sought for Reminyl for Alzheimer's disease

Aronex regains worldwide marketing rights to Atragen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...